Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, DiaMedica Therapeutics Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 36.84m or -- of revenues. In addition the company used 18.73m for operations while cash used for investing totalled 18.30m.
Cash flow per share | -0.5229 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.25 |
---|---|
Tangible book value per share | 1.25 |
More ▼
Balance sheet in USDView more
Current ratio | 17.82 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0006 |
---|---|
Total debt/total capital | 0.0006 |
More ▼